7.0977
前日終値:
$7.01
開ける:
$6.94
24時間の取引高:
8.55M
Relative Volume:
0.99
時価総額:
$2.43B
収益:
-
当期純損益:
$-75.80M
株価収益率:
-20.28
EPS:
-0.35
ネットキャッシュフロー:
$-68.07M
1週間 パフォーマンス:
+46.02%
1か月 パフォーマンス:
+68.57%
6か月 パフォーマンス:
+249.59%
1年 パフォーマンス:
+162.84%
Nuvation Bio Inc Stock (NUVB) Company Profile
名前
Nuvation Bio Inc
セクター
電話
(415) 754-3517
住所
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
NUVB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
NUVB
Nuvation Bio Inc
|
7.10 | 2.40B | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.06 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
760.89 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
437.57 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
922.65 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
200.09 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-19 | 開始されました | B. Riley Securities | Buy |
| 2025-09-30 | 開始されました | Jefferies | Buy |
| 2025-04-23 | 開始されました | Citizens JMP | Mkt Outperform |
| 2024-03-27 | アップグレード | Jefferies | Hold → Buy |
| 2024-03-26 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-01-06 | ダウングレード | Jefferies | Buy → Hold |
| 2022-08-02 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-05-04 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2021-04-06 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-03-08 | 開始されました | BMO Capital Markets | Outperform |
| 2021-03-08 | 開始されました | BTIG Research | Buy |
| 2021-03-08 | 開始されました | Cowen | Outperform |
| 2021-03-08 | 開始されました | Jefferies | Buy |
| 2021-03-08 | 開始されました | Wedbush | Outperform |
すべてを表示
Nuvation Bio Inc (NUVB) 最新ニュース
Is Nuvation Bio Inc. Class stock ideal for retirement investorsJuly 2025 Closing Moves & Accurate Technical Buy Alerts - newser.com
Nuvation Bio Reports Positive Phase 2 Study Results - MSN
Citizens Maintains Nuvation Bio (NUVB) Market Outperform Recommendation - Nasdaq
Nuvation Bio (NUVB) Is Up 49.5% After Strong Phase 2 Glioma Data Shows Promising Progression-Free Survival - simplywall.st
Nuvation Bio: Taking Care With Rapid Rises In Valuation (Rating Downgrade) (NUVB) - Seeking Alpha
Nuvation Bio stock price target raised to $10 from $8 at Citizens - Investing.com Australia
Nuvation Bio Surges On Ibtrozi Momentum And B. Riley Buy Rating (NYSE:NUVB) - Seeking Alpha
Will Nuvation Bio Inc. Class stock draw ESG focused fundsJuly 2025 Levels & Weekly Momentum Stock Picks - newser.com
Nuvation Bio jumps 49% on blockbuster debut for lung cancer drug | Tap to know more | Inshorts - Inshorts
Nuvation Bio stock price target raised to $10 from $8 at Citizens By Investing.com - Investing.com India
What is the fair value estimate for Nuvation Bio Inc. Warrants stock in 20252025 Investor Takeaways & Safe Investment Capital Preservation Plans - newser.com
10 Stocks Beating Wall Street at its Own Game - Insider Monkey
Nuvation Bio (NUVB) Jumps to 3-Year High on Bullish Coverage - Finviz
Nuvation Bio’s CMO Cashes Out: What This Stock Sale Means - TipRanks
How big funds are accumulating Nuvation Bio Inc. Warrants stockJuly 2025 Momentum & Reliable Intraday Trade Alerts - newser.com
Is Nuvation Bio Inc. Warrants stock a defensive play amid uncertaintyQuarterly Market Review & High Return Trade Opportunity Guides - newser.com
Is Nuvation Bio Inc. stock recession proofJuly 2025 Sentiment & AI Driven Stock Price Forecasts - newser.com
Is Nuvation Bio Inc. stock overvalued by current metricsWeekly Trend Recap & Accurate Technical Buy Alerts - newser.com
Nuvation Bio stock initiated with Buy rating at B.Riley on strong Ibtrozi launch By Investing.com - Investing.com Nigeria
B. Riley Securities Initiates Coverage of Nuvation Bio (NUVB) with Buy Recommendation - Nasdaq
Will Nuvation Bio Inc. Warrants stock benefit from mergersJuly 2025 Short Interest & Weekly Top Performers Watchlists - newser.com
Nuvation Bio (NUVB) Soars on IBTROZI's Blockbuster Launch and Stellar Q3 2025 Performance - FinancialContent
Nuvation Bio Shines On Breakthroughs And Analyst Upgrades - Finimize
Nuvation Bio rises as B. Riley starts at Buy on launch trajectory for lead drug - MSN
How Nuvation Bio Inc. Class stock performs in easing cyclesEarnings Summary Report & Weekly Top Gainers Alerts - newser.com
Nuvation Bio Shares Have Room to Run on Ibtrozi Momentum, Wedbush Says - MarketScreener
Nuvation Bio stock initiated with Buy at B. Riley (NUVB:NYSE) - Seeking Alpha
What candlestick patterns are forming on Nuvation Bio Inc.July 2025 Sector Moves & Reliable Breakout Forecasts - newser.com
Nuvation Bio (NUVB) Stock: Two Analysts Predict Major Upside on Promising Cancer Drug - parameter.io
Nuvation Bio stock hits 52-week high at $5.57 - Investing.com
Nuvation Bio stock hits 52-week high at $5.57 By Investing.com - Investing.com Nigeria
How Nuvation Bio Inc. stock reacts to inflationary pressuresMarket Risk Report & Safe Entry Momentum Tips - newser.com
Will Nuvation Bio Inc. Warrants stock announce a stock splitWeekly Profit Analysis & Real-Time Chart Pattern Alerts - newser.com
B. Riley Initiates Coverage on Nuvation Bio With Buy Rating, $12 Price Target - MarketScreener
How big funds are accumulating Nuvation Bio Inc. Class stockWeekly Investment Summary & Fast Moving Trade Plans - newser.com
How Nuvation Bio Inc. stock performs in stagflationMarket Volume Report & High Accuracy Trade Signal Alerts - newser.com
Nuvation Bio initiated with a Buy at B. Riley - TipRanks
Nuvation Bio stock initiated with Buy rating at B.Riley on strong Ibtrozi launch - Investing.com Australia
Nuvation Bio Inc (NUVB) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):